En Es
Products
Covid-19
Companies
Pre-Owned
News
Events
About Us       Join now!
Categories

Browse Products by Category

Critical Care

Emergency Medicine

Intensive Care

Respiratory Care

Anesthesiology Systems

Home Care

Rehabilitation

Other

Hospital Infrastructure

IT Equipment

Transportation Systems

Waste Management

Other

Medical Imaging

Computed Tomography

Digital Radiography

Image Management Systems

Interventional Radiology

Magnetic Resonance Imaging

Mammography

PACS/RIS

Positron Emission Tomography

Radiation Safety

Radiography

Single-Photon Emission Computed Tomography

Ultrasound

Other

Patient Care

Bariatric Care

Beds

Examination Equipment

Other

Surgery

Endoscopy

Laparoscopy

Laser Surgery

Operating Room Equipment

Sterilization

Surgical Implants

Surgical Instruments

Waste Management

Other

Expo: Clinical Laboratory

Blood & Blood Gas Analyzers

Cell Counters

Centrifuges

Clinical Chemistry Analyzer

Coagulation Analyzers

General Lab

Hematology Analyzers

Immunoassay Systems

Lab Glassware

Microplate Reader

Microscopes

Pipettes

Rapid Tests

Ready-to-use Kits for Analysis

Urine Analyzer

Point-Of-Care Testing

Browse Products by Category

Close

DIASORIN

DIASORIN

DiaSorin develops, produces and commercializes diagnostic tests for a wide range of clinical areas. The company’s tests are designed for hospital and private testing laboratories in the markets of immunodiagnostics and molecular diagnostics.
Products Covid-19NewsSummary
Close

Covid-19 DIASORIN

Clinical Laboratory

SARS-CoV-2 Ag Assay
LIAISON SARS-CoV-2 Ag

The LIAISON SARS-CoV-2 Ag assay is a chemiluminescence sandwich-immunoassay (CLIA) based technology for the quantitative determination of Nucleocapsid antigen protein from SARS-CoV-2 samples - in nasal swab (NS), nasopharyngeal swab (NPS) eluted in UTM/VTM directly from individuals who are suspected of COVID-19 by their healthcare provider within the first 10 days of the onset of symptoms. The assay is a unique quantitative solution to detect suspected COVID-19 patients, do contact tracing and rapidly implement isolation procedures for those patients who have been infected and might be able to spread SARS-CoV-2.
More details

SARS-CoV-2 IgM Assay
LIAISON SARS-CoV-2 IgM

The LIAISON SARS-CoV-2 IgM is a fully automated assay to be run on LIAISON X for detecting IgM antibody to the SARS-CoV-2 virus that causes COVID-19. The assay offers high sensitivity and specificity to ensure accurate results along the infection window.
More details

SARS-CoV-2 TrimericS IgG Assay
LIAISON SARS-CoV-2 TrimericS IgG Assay

The LIAISON SARS-CoV-2 TrimericS IgG Assay is a new generation of chemiluminescence immunoassay (CLIA), for the quantitative determination of anti-trimeric spike protein specific IgG antibodies to SARS-CoV-2 in human serum or plasma samples. The assay is intended as an aid in the diagnosis of CoVID-19 and to support the study of the immune status of infected patients by providing an indication of the presence of neutralizing IgG antibodies against SARS-CoV-2.
More details

SARS-CoV-2 S1/S2 IgG Assay
LIAISON SARS-CoV-2 S1/S2 IgG

The LIAISON SARS-CoV-2 S1/S2 IgG is a quantitative assay for the detection of IgG antibodies against S1/S2 antigens of SARS-CoV-2. The fully automated solution with a throughput of up to 170 results/hour on LIAISON XL has high sensitivity and specificity to ensure accurate results. The quantitative assay with correlation to neutralizing antibodies can be used as an upstream pre-screening tool.
More details
Close

News of DIASORIN

DiaSorin to Acquire Siemens' ELISA Immunodiagnostics Business

01 Aug 2017
DiaSorin to Acquire Siemens' ELISA Immunodiagnostics Business
DiaSorin S.p.A. has entered into an agreement to acquire Siemens Healthineers’ micro-titre-based ELISA immunodiagnostic business portfolio and related tangible and intangible assets, including customer sales and distribution contracts, installed base of instruments and relevant intellectual property.
Read More
Close

About DIASORIN

DiaSorin develops, produces and commercializes diagnostic tests for a wide range of clinical areas. The company’s tests are designed for hospital and private testing laboratories in the markets of immunodiagnostics and molecular diagnostics.

Recently updated

H. pylori Test
LIAISON H. pylori Diagnostic Solution

The LIAISON H. pylori Diagnostic Solution comprises LIAISON Meridian H. pylori SA and LIAISONH. pylori IgG tests for patients suspected of having H. pylori infection and measuring post-therapy response. The assay provides a simple alternative to the urea breath test and provides rapid results in 30 minutes, allowing doctors to immediately start appropriate treatment.
More details

S-100B Protein Test
LIAISON S100

LIAISON S100 is an automated CLIA assay for the determination of protein S-100B in human serum and CSF (cerebrospinal fluid). The test can be used as an aid in the diagnosis of malignant melanoma and as an aid in the diagnosis and prognosis of traumatic brain injury.
More details

Tissue Polypeptide Antigen Test
LIAISON TPA-M

The LIAISON TPA-M is an automated CLIA assay for the quantitative determination of tissue polypeptide antigen (TPA) in human serum. The test can be used as an aid in the diagnosis of patients with carcinomas such as lung cancer, breast cancer, bladder cancer, and therapy monitoring after tumor surgery or treatment.
More details

Clinical Laboratory

H. pylori Test
LIAISON H. pylori Diagnostic Solution

The LIAISON H. pylori Diagnostic Solution comprises LIAISON Meridian H. pylori SA and LIAISONH. pylori IgG tests for patients suspected of having H. pylori infection and measuring post-therapy response. The assay provides a simple alternative to the urea breath test and provides rapid results in 30 minutes, allowing doctors to immediately start appropriate treatment.
More details

S-100B Protein Test
LIAISON S100

LIAISON S100 is an automated CLIA assay for the determination of protein S-100B in human serum and CSF (cerebrospinal fluid). The test can be used as an aid in the diagnosis of malignant melanoma and as an aid in the diagnosis and prognosis of traumatic brain injury.
More details

Tissue Polypeptide Antigen Test
LIAISON TPA-M

The LIAISON TPA-M is an automated CLIA assay for the quantitative determination of tissue polypeptide antigen (TPA) in human serum. The test can be used as an aid in the diagnosis of patients with carcinomas such as lung cancer, breast cancer, bladder cancer, and therapy monitoring after tumor surgery or treatment.
More details

Hepatitis B Virus Test
LIAISON HAV IgM Assay

The LIAISON HAV IgM assay uses chemiluminescent immunoassay (CLIA) technology for the qualitative determination of IgM immunoglobulin to hepatitis A virus (IgM anti-HAV) in human serum or plasma samples. The test has to be performed on the LIAISON analyzer family.
More details

Measles Virus Antibody Test
LIAISON Measles IgM Assay

The LIAISON Measles IgM assay uses chemiluminescence immunoassay (CLIA) technology for the qualitative determination of specific IgM antibodies to measles virus in human serum or plasma samples. It is intended to be used as an aid in the determination of serological status to measles virus and has to be performed on the LIAISON analyzer.
More details

Rubella Virus Antibody Test
LIAISON Rubella IgG Assay

The LIAISON Rubella IgG assay uses chemiluminescence immunoassay (CLIA) technology for the quantitative determination of specific IgG antibodies to rubella virus in human serum or plasma samples. Designed to be performed on the LIAISON analyzer family, the sensitive assay is able to detect low IgG antibody titers present in vaccinated population, reducing the number of samples to be confirmed.
More details

Thyroglobulin (Tg) Assay
LIAISON Anti-Tg

LIAISON Anti-Tg is an in vitro assay for the quantitative determination of autoantibodies against thyroglobulin (Tg) in human serum as well as in EDTA and heparinised human plasma. The test has to be performed on the LIAISON Analyzer which is capable of running 94 patient samples at the same time.
More details

Rotavirus Assay
LIAISON Rotavirus

The DiaSorin LIAISON Rotavirus assay is an in vitro diagnostic chemiluminescent immunoassay (CLIA) intended for the qualitative determination of rotavirus antigen in human stool specimens and must be performed on the LIAISON Analyzer. The test is used primarily as an aid for the diagnosis of acute viral gastroenteritis and the results are to be used in conjunction with information obtained from the patients’ clinical evaluation and other diagnostic procedures.
More details

1-84 PTH Chemiluminescent Immunoassay
LIAISON 1-84 PTH Assay

The LIAISON 1-84 PTH assay is a chemiluminescent immunoassay (CLIA) intended for the quantitative determination of 1-84 PTH without cross-reaction to 7-84 PTH fragment in human serum and EDTA plasma. Measurements of parathyroid hormone levels are used in the differential diagnosis of hypercalcemia and hypocalcemia resulting from disorders of phosphorus and calcium metabolism. The test has to be performed on the LIAISON Analyzer which is capable of running 94 patient samples at the same time.
More details

M. Tuberculosis Indirect Test
LIAISON QuantiFERON-TB Gold Plus

The LIAISON QuantiFERON-TB Gold Plus assay is an in vitro diagnostic test for the detection of interferon-y (IFN-y) in human lithium heparin plasma by chemiluminescence immunoassay (CUA) using the LIAISON XL Analyzer. The assay is a qualitative indirect test for M. tuberculosis infection (including disease) and is intended for use in conjunction with risk assessment, radiography, and other medical and diagnostic evaluations to assist the clinician in making individual patient management decisions.
More details

Procalcitonin Chemiluminescence Immunoassay
LIAISON BRAHMS PCT II GEN

LIAISON BRAHMS PCT II GEN assay uses chemiluminescence immunoassay (CLIA) technology for the in vitro quantitative determination of Procalcitonin in human serum and plasma specimens. The assay is intended for use, in conjunction with other laboratory findings and clinical assessments, to aid in the risk analysis of critically ill patients for progression of relevant bacterial infections.
More details

Tuberculosis Molecular Test
LIAISON QuantiFERON -TB Gold Plus

The LIAISON QuantiFERON -TB Gold Plus, developed in partnership with QIAGEN, is an in vitro diagnostic test for the detection of interferon-y (IFN-y) in human lithium heparin plasma by chemiluminescence immunoassay (CUA) using the LIAISON XL Analyzer. The assay is a qualitative indirect test for M. tuberculosis infection (including disease) and is intended for use in conjunction with risk assessment, radiography, and other medical and diagnostic evaluations to assist the clinician in making individual patient management decisions.
More details

Bacterial/Viral Infection Blood Test
LIAISON MeMed BV

The LIAISON MeMed BV test is the first fully automated solution, which utilizes host response-based data to enable physicians to differentiate accurately between bacterial and viral infections, supporting fast and better-informed treatment and patient management decisions. From a simple serological sample, it automatically measures, analyzes and integrates the levels of three host immune proteins into a single and simple score, showing the likelihood of a bacterial immune response or co-infection versus a likely viral immune response. The high-throughput, high-quality chemiluminescent assay easily identifies the source of a patient’s infection using the LIAISON XL automatic analyzer.
More details

SARS-CoV-2 S1/S2 IgG Assay
LIAISON SARS-CoV-2 S1/S2 IgG

The LIAISON SARS-CoV-2 S1/S2 IgG is a quantitative assay for the detection of IgG antibodies against S1/S2 antigens of SARS-CoV-2. The fully automated solution with a throughput of up to 170 results/hour on LIAISON XL has high sensitivity and specificity to ensure accurate results. The quantitative assay with correlation to neutralizing antibodies can be used as an upstream pre-screening tool.
More details

SARS-CoV-2 TrimericS IgG Assay
LIAISON SARS-CoV-2 TrimericS IgG Assay

The LIAISON SARS-CoV-2 TrimericS IgG Assay is a new generation of chemiluminescence immunoassay (CLIA), for the quantitative determination of anti-trimeric spike protein specific IgG antibodies to SARS-CoV-2 in human serum or plasma samples. The assay is intended as an aid in the diagnosis of CoVID-19 and to support the study of the immune status of infected patients by providing an indication of the presence of neutralizing IgG antibodies against SARS-CoV-2.
More details

SARS-CoV-2 IgM Assay
LIAISON SARS-CoV-2 IgM

The LIAISON SARS-CoV-2 IgM is a fully automated assay to be run on LIAISON X for detecting IgM antibody to the SARS-CoV-2 virus that causes COVID-19. The assay offers high sensitivity and specificity to ensure accurate results along the infection window.
More details

SARS-CoV-2 Ag Assay
LIAISON SARS-CoV-2 Ag

The LIAISON SARS-CoV-2 Ag assay is a chemiluminescence sandwich-immunoassay (CLIA) based technology for the quantitative determination of Nucleocapsid antigen protein from SARS-CoV-2 samples - in nasal swab (NS), nasopharyngeal swab (NPS) eluted in UTM/VTM directly from individuals who are suspected of COVID-19 by their healthcare provider within the first 10 days of the onset of symptoms. The assay is a unique quantitative solution to detect suspected COVID-19 patients, do contact tracing and rapidly implement isolation procedures for those patients who have been infected and might be able to spread SARS-CoV-2.
More details

Hepatitis D Assay
LIAISON XL Anti-HDV

The LIAISON XL Anti-HDV assay uses chemiluminescence immunoassay (CLIA) technology for the qualitative detection of total antibodies to hepatitis D virus in human serum and plasma samples. The assay results, in conjunction with other laboratory results and clinical information, are intended to be used as an aid in the diagnosis of HDV infection and as a screening test for organ and tissue donors.
More details

Calprotectin Test
LIAISON Calprotectin Test

The LIAISON Calprotectin test provides fast, reliable and automated detection of calprotectin in feces that is a marker used to help differentiate IBS (Irritable Bowel Syndrome) from IBD (Inflammatory Bowel Disease) and assess disease activity in IBD. Calprotectin is a heterocomplex composed of the calcium and zinc binding proteins S100A8 and S100A9, is resistant to enzymatic degradation, and can be easily measured in feces, making it ideal for direct detection by immunochemistry methods.
More details

Tuberclosis Assay
LIAISON QuantiFERON-TB Gold Plus

The LIAISON QuantiFERON-TB Gold Plus is a fully automated CLIA assay to aid in the diagnosis of TB infection and can detect both active and latent TB infection. It is designed to work with QIAGEN Quantiferon-TB Gold Plus Blood Collection Tubes which employ TB-specific antigens that elicit both CD8+ and CD4+ T cell responses for accurate assessment of cell-mediated immune response to TB infection.
More details

CLIA Analyzer
LIAISON XS

The LIAISON XS is a fully-automated CLIA analyzer with an efficient design and reduced dimensions that helps achieve higher efficiency and effectively perform low volume specialties and routine tests. It offers a new level of reliability and higher performance in results quality and workflow efficiency and optimization.
More details

ELISA Reader
ELx800

The ELx800 ELISA reader has a compact footprint and proven robust design that makes it an ideal solution for several microplate-based biological assays. Available in 6-, 12-, 24-, 48-, 96- and 384-well capability to meet a variety of assay needs, it is designed for applications within the clinical, biotechnology research and pharmaceutical laboratory.
More details

CLIA Analyzer
LIAISON

The LIAISON CLIA analyzer combines a flexible operating module with a broad menu of assays, resulting in high efficiency due to its lengthy walk-away time. It offers the possibility to run up to 15 different assays at a time, providing rational everyday testing even with a small number of samples.
More details

Zika Virus IgM Assay
LIAISON XL Zika Capture IgM

The LIAISON XL Zika Capture IgM is a first-of-its-kind assay for Zika virus IgM detection that yields results in as little as 51 minutes. The capture assay and the use of recombinant specific antigen assure superior specificity without cross reactions with other Arboviruses.
More details

ELISA Analyzer
Freedom EVOlyzer

The Freedom EVOlyzer is a dedicated platform for the automation of microplate¬based chromogenic ELISAs, and can be easily adapted to meet the changing workflow and throughput requirements of today’s diagnostic laboratory. Controlled by the easy-to-use Freedom EVOlution software, the platform offers outstanding flexibility for a wide variety of ELISA protocols and is designed to reduce hands-on time for ELISA processing.
More details

Chemiluminescence Analyzer
LIAISON XL

The LIAISON XL is a fully automated chemiluminescence analyzer, performing complete sample processing (sample pre-dilutions, sample and reagent dispensing, incubations, wash processes, etc.) as well as measurement and evaluation. It adopts the “Flash” chemiluminescence technology (CLIA) with paramagnetic microparticle solid phase and optimizes throughput by splitting the pipetting phases of reagents and samples into different cycles.
More details

Microtiter Plate Analyzer
ETI-Max 3000

The ETI-Max 3000 is a fully automated microtiter plate analyzer that performs the complete sample processing (sample pre-dilutions, sample and reagent dispensing, incubations, wash processes, plate transports) as well as photometric measurement and evaluation. The instrument is controlled by Windows PC software which allows the user to process pre-defined assays as well as assays programmed by the user.
More details
Copyright © 2000-2024 TradeMed.com. All rights reserved. | Terms And Conditions